Jones HE - Search Results

1

Lipid composition of subcellular membranes from larvae and prepupae of Drosophila melanogaster.

Jones HE, Harwood JL, Bowen ID, Griffiths G. Jones HE, et al. Lipids. 1992 Dec;27(12):984-7. doi: 10.1007/BF02535576. Lipids. 1992. PMID: 1487960

2

Targeted bioluminescent indicators in living cells.

Sala-Newby GB, Badminton MN, Evans WH, George CH, Jones HE, Kendall JM, Ribeiro AR, Campbell AK. Sala-Newby GB, et al. Among authors: jones he. Methods Enzymol. 2000;305:479-98. doi: 10.1016/s0076-6879(00)05508-7. Methods Enzymol. 2000. PMID: 10812621 No abstract available.

3

Acid phosphatase activity in the larval salivary glands of developing Drosophila melanogaster.

Jones HE, Bowen ID. Jones HE, et al. Cell Biol Int. 1993 Mar;17(3):305-15. doi: 10.1006/cbir.1993.1066. Cell Biol Int. 1993. PMID: 8513298

4

The accumulation of pentamidine into rat lung slices and its interaction with putrescine.

Jones HE, Blundell GK, Wyatt I, John RA, Farr SJ, Richards RJ. Jones HE, et al. Biochem Pharmacol. 1992 Feb 4;43(3):431-7. doi: 10.1016/0006-2952(92)90560-6. Biochem Pharmacol. 1992. PMID: 1540201

5

The accumulation of pentamidine and the toxic effects of the drug, its selected analogues and metabolites on isolated alveolar cells.

Jones HE, Blundell GK, Tidwell RR, Hall JE, Farr SJ, Richards RJ. Jones HE, et al. Toxicology. 1993 Jun 4;80(1):1-12. doi: 10.1016/0300-483x(93)90072-z. Toxicology. 1993. PMID: 8322368

6

Response of cell growth and retinoic acid receptor expression to retinoic acid in neoplastic and non-neoplastic prostate cell lines.

Jones HE, Eaton CL, Barrow D, Dutkowski C, Griffiths K. Jones HE, et al. Prostate. 1997 Feb 15;30(3):174-82. doi: 10.1002/(sici)1097-0045(19970215)30:3<174::aid-pros5>3.0.co;2-m. Prostate. 1997. PMID: 9122042

7

Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines.

Jones HE, Eaton CL, Barrow D, Dutkowski CM, Gee JM, Griffiths K. Jones HE, et al. Prostate. 1997 Mar 1;30(4):219-31. doi: 10.1002/(sici)1097-0045(19970301)30:4<219::aid-pros1>3.0.co;2-g. Prostate. 1997. PMID: 9111599

8

New EGF-R selective tyrosine kinase inhibitor reveals variable growth responses in prostate carcinoma cell lines PC-3 and DU-145.

Jones HE, Dutkowski CM, Barrow D, Harper ME, Wakeling AE, Nicholson RI. Jones HE, et al. Int J Cancer. 1997 Jun 11;71(6):1010-8. doi: 10.1002/(sici)1097-0215(19970611)71:6<1010::aid-ijc17>3.0.co;2-h. Int J Cancer. 1997. PMID: 9185705

9

Escherichia coli lacking the AcrAB multidrug efflux pump also lacks nonproteinaceous, PHB-polyphosphate Ca2+ channels in the membrane.

Jones HE, Holland IB, Jacq A, Wall T, Campbell AK. Jones HE, et al. Biochim Biophys Acta. 2003 May 2;1612(1):90-7. doi: 10.1016/s0005-2736(03)00082-8. Biochim Biophys Acta. 2003. PMID: 12729934

10

Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination.

Nicholson RI, Hutcheson IR, Knowlden JM, Jones HE, Harper ME, Jordan N, Hiscox SE, Barrow D, Gee JM. Nicholson RI, et al. Among authors: jones he. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):346S-54S. doi: 10.1158/1078-0432.ccr-031206. Clin Cancer Res. 2004. PMID: 14734490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results